Canada Goose (TSX:GOOS) Stock: How Bad Is the Coronavirus Impact?

Canada Goose Holdings Inc (TSX:GOOS)(NYSE:GOOS) is a stock that can double or triple in value, but what will be the impact of the coronavirus?

| More on:
Coronavirus written newspaper close up shot to the text.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The coronavirus pandemic has hit stocks hard. Few industries have experienced more pain than retail. Consumer spending has fallen dramatically, especially for luxury goods. Canada Goose Holdings Inc (TSX:GOOS)(NYSE:GOOS) is on the front lines of this impact.

Year to date, GOOS stock is down 40%. But the coronavirus is only the latest challenge for the company. Since their highs in 2018, shares have lost two-thirds of their value.

Canada Goose stock was ripe for a correction, especially as shares once traded at 150 times trailing earnings. But at some point, the correction will go too far. Already, GOOS stock looks like the bargain of the decade on several valuation metrics, yet the ultimate impact of the coronavirus remains unclear.

How much will the coronavirus hurt Canada Goose? Are shares a buy today or is it best to wait?

Understand the impact

The coronavirus presents a broad challenge for Canada Goose. But before we cover the headwinds, it’s helpful to understand how the company intends to grow to understand connection between the two should be clear.

Canada Goose is a luxury retailer best known for its $1,000 jackets used by professional mountaineers and scientists in Antarctica. The company’s products are renowned for their quality and the hefty price tag represents that commitment.

Founded in Toronto, the company still generates one-third of its sales from Canada. Another one-third comes from the U.S., with the remainder a mix of international sources. Last year, Canada and U.S. sales rose by roughly 25%. International sales, meanwhile, skyrocketed by 61%.

The international opportunity is still a minority of revenue, but it represents Canada Goose’s biggest growth runway. The company recently opened its first stores in China, the largest luxury market in the world. If its success can be replicated in markets like China, South Korea, and Japan, GOOS stock could triple in value.

The coronavirus has placed a big delay on that international expansion. Consumer spending is significantly lower for luxury goods. Construction on new stores has come to a halt. And retail shopping in general, particularly in physical locations, could take years to return to baseline.

But now trading at 25 times earnings — an 85% discount to its previous valuation — is it time to buy GOOS stock?

Buy Canada Goose stock?

Here’s the good news: Canada Goose isn’t going away. It has a multi-decade, storied history that’s difficult to replicate. Its reputation is seared into the psyches of its customer base.

Before the crash, roughly 90% of its buyers reported that they’ll return to the company for their next jacket purchase. That’s quite a feat considering the garments can cost $1,000 or more.

The long-term international growth story won’t go away either. These markets remain a perfect fit for the company once conditions normalize.

But when exactly will retail sales return to normal? That’s the biggest question plaguing the stock. Long-term investors can capitalize.

It’s almost a certainty that Canada Goose will survive the pandemic. It’s also likely that the days of rapid growth will return, eventually. Will that occur in a few months or a few years? It’s difficult to say, but if you’re willing to buy and hold this stock for a decade, the wait will likely be worth it.

But if you’re not ready to commit, take a look at some other opportunities that the market has presented in recent weeks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Canada Goose Holdings. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »